Skip to content

Study evaluating various parameters in the blood and tissue of patients with endocrine orbitopathy in Graves' disease. An approach to personalized medicine.

Study evaluating various parameters in the blood and tissue of patients with endocrine orbitopathy in Graves' disease. An approach to personalized medicine.

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00038656
Enrollment
300
Registered
2025-12-05
Start date
2025-06-06
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

E05.0 H06.3 - Graves' disease with endocrine orbitopathy E05.0 H06.3

Interventions

Group 1: Arm 1: Graves' disease patients with varying degrees of endocrine orbitopathy are surveyed using the following questionnaires: • Specific questionnaire on quality of life for patients with Gr

Sponsors

Uniklinikum Essen
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients over 18 with Graves' disease, both with and without endocrine orbitopathy of varying severity.

Exclusion criteria

Exclusion criteria: under the age of 18

Design outcomes

Primary

MeasureTime frame
Examination of the tissue and blood samples taken from patients as required Special attention should be paid to satisfaction with appearance in the long term after completion of all operations (decompression, strabismus, eyelids). This should be determined using the following questionnaires • EUGOGO • FACE Q • Specific questionnaire on the operation (explicitly designed for orbital decompression patients) • Quality of life (general questionnaire from the WHO)

Countries

Germany

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Jun 29, 2026